CLINICAL TRIAL
Accepted on 30 Jun 2025
Anti-CD19 CAR-T cell therapy in relapsed/refractory t(8;21) acute myeloid leukemia with aberrant CD19 expression
doi 10.3389/fimmu.2025.1617589
- 194 views
1,523
Total downloads
7,263
Total views and downloads
CLINICAL TRIAL
Accepted on 30 Jun 2025
CASE REPORT
Published on 05 Jun 2025
ORIGINAL RESEARCH
Published on 03 Jun 2025
ORIGINAL RESEARCH
Published on 24 Dec 2024
ORIGINAL RESEARCH
Published on 18 Nov 2024